Anti-CPVL/ HVLP functional antibody

Anti-CPVL/ HVLP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CPVL/CPVL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0118-Ab-1/ GM-Tg-hg-SE0118-Ab-2Anti-Human CPVL monoclonal antibodyHuman
GM-Tg-rg-SE0118-Ab-1/ GM-Tg-rg-SE0118-Ab-2Anti-Rat CPVL monoclonal antibodyRat
GM-Tg-mg-SE0118-Ab-1/ GM-Tg-mg-SE0118-Ab-2Anti-Mouse CPVL monoclonal antibodyMouse
GM-Tg-cynog-SE0118-Ab-1/ GM-Tg-cynog-SE0118-Ab-2Anti-Cynomolgus/ Rhesus macaque CPVL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0118-Ab-1/ GM-Tg-felg-SE0118-Ab-2Anti-Feline CPVL monoclonal antibodyFeline
GM-Tg-cang-SE0118-Ab-1/ GM-Tg-cang-SE0118-Ab-2Anti-Canine CPVL monoclonal antibodyCanine
GM-Tg-bovg-SE0118-Ab-1/ GM-Tg-bovg-SE0118-Ab-2Anti-Bovine CPVL monoclonal antibodyBovine
GM-Tg-equg-SE0118-Ab-1/ GM-Tg-equg-SE0118-Ab-2Anti-Equine CPVL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0118-Ab-1/ GM-Tg-hg-SE0118-Ab-2; GM-Tg-rg-SE0118-Ab-1/ GM-Tg-rg-SE0118-Ab-2;
GM-Tg-mg-SE0118-Ab-1/ GM-Tg-mg-SE0118-Ab-2; GM-Tg-cynog-SE0118-Ab-1/ GM-Tg-cynog-SE0118-Ab-2;
GM-Tg-felg-SE0118-Ab-1/ GM-Tg-felg-SE0118-Ab-2; GM-Tg-cang-SE0118-Ab-1/ GM-Tg-cang-SE0118-Ab-2;
GM-Tg-bovg-SE0118-Ab-1/ GM-Tg-bovg-SE0118-Ab-2; GM-Tg-equg-SE0118-Ab-1/ GM-Tg-equg-SE0118-Ab-2
Products NameAnti-CPVL monoclonal antibody
Formatmab
Target NameCPVL
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CPVL benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0118-Ag-1Recombinant multi-species CPVL/ HVLP protein


    Target information

    Target IDGM-SE0118
    Target NameCPVL
    Gene ID54504,71287,502774,697111,611483,101085706,534518,100069591
    Gene Symbol and Synonyms4933436L16Rik,CPVL,HVLP
    Uniprot AccessionQ9H3G5,Q4QR71
    Uniprot Entry NameCPVL_HUMAN,CPVL_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000106066
    Target ClassificationN/A

    The target: CPVL, gene name: CPVL, also named as HVLP. The protein encoded by this gene is a carboxypeptidase and bears strong sequence similarity to serine carboxypeptidases. Carboxypeptidases are a large class of proteases that act to cleave a single amino acid from the carboxy termini of proteins or peptides. The exact function of this protein, however, has not been determined. [provided by RefSeq, Jan 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.